Insider Trading & Ownership of Ming Xian

Location
Baltimore, MD
Summary
The estimated net worth of Ming Xian is at least $430,393 dollars as of 26 Jun 2025. Ming Xian is the Director of MEDIFAST INC and owns shares of MEDIFAST INC (MED) stock worth about $430.4K.
Signature
/s/ Jason L. Groves, attorney-in-fact
All Insider Reports
All Insider Reports

Follow Filing Activity

Follow Ming Xian and return when a new Insider Trading filing changes the record on this page.

This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.

Key facts

  • Ming Xian has 1 issuer position tracked on this page.
  • Estimated disclosed ownership value: $430,393.
  • Recent insider filing activity is available below.

Change

  • Largest disclosed position: MEDIFAST INC ($430,393).
  • Past-year value change for that position: .

Research use

  • This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
  • You can cross-check role, issuer, and filing chronology directly against the SEC source.

Evidence

Filed on Form 4

Insider ownership context is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Ownership of Ming Xian

MED Forms 3/4/5

MEDIFAST INC

Relationship
Director
Holdings value
$430,393
Past year net change
Change %
Report period
25 Jun 2025

Insider Transactions Reported by Ming Xian:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .